Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023
Now in its seventh year, Acquisition International’s M&A Awards recognizes the excellence of top executives, analysts, investors, and professionals in the M&A sector across diverse industries. In the healthcare domain, Juniper Biologics stands out for the second consecutive year, this time for its acquisition of Caris Molecular Intelligence®, a tumour profiling service for Asia. Juniper Biologics […]